Judith van Holten

1.1k total citations
12 papers, 734 citations indexed

About

Judith van Holten is a scholar working on Epidemiology, Rheumatology and Hepatology. According to data from OpenAlex, Judith van Holten has authored 12 papers receiving a total of 734 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Epidemiology, 5 papers in Rheumatology and 5 papers in Hepatology. Recurrent topics in Judith van Holten's work include Hepatitis B Virus Studies (5 papers), Hepatitis C virus research (5 papers) and Rheumatoid Arthritis Research and Therapies (5 papers). Judith van Holten is often cited by papers focused on Hepatitis B Virus Studies (5 papers), Hepatitis C virus research (5 papers) and Rheumatoid Arthritis Research and Therapies (5 papers). Judith van Holten collaborates with scholars based in United States, Switzerland and Netherlands. Judith van Holten's co-authors include Paul P. Tak, C Plater-Zyberk, Marc Bulterys, Ying Lu, Roger Chou, Margriet J. Vervoordeldonk, Kyoko Yoshida, Yusuke Shimakawa, Tianshuo Zhao and Anna Funk and has published in prestigious journals such as Annals of the Rheumatic Diseases, The Lancet Infectious Diseases and Arthritis Research & Therapy.

In The Last Decade

Judith van Holten

12 papers receiving 723 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Judith van Holten United States	10	337	323	202	168	122	12	734
Kouzaburo Yamaji Japan	14	403 1.2×	394 1.2×	76 0.4×	177 1.1×	110 0.9×	27	758
Karl‐H. Meyer zum Büschenfelde Germany	9	261 0.8×	250 0.8×	198 1.0×	317 1.9×	43 0.4×	14	676
Ewa Terczyńska‐Dyla Denmark	7	204 0.6×	174 0.5×	67 0.3×	314 1.9×	119 1.0×	12	556
Shozo Miyake Japan	16	356 1.1×	437 1.4×	72 0.4×	56 0.3×	47 0.4×	38	643
Emil Miskovsky United States	15	427 1.3×	382 1.2×	72 0.4×	182 1.1×	34 0.3×	18	813
K. H. Wiedmann Germany	13	396 1.2×	348 1.1×	73 0.4×	142 0.8×	44 0.4×	33	815
Tatsuji Komatsu Japan	15	389 1.2×	375 1.2×	52 0.3×	317 1.9×	173 1.4×	37	1.0k
Sayuri Nitta Japan	15	408 1.2×	489 1.5×	59 0.3×	170 1.0×	51 0.4×	40	681
Chieko Ishiwata Japan	11	479 1.4×	471 1.5×	56 0.3×	62 0.4×	104 0.9×	51	910
F.B. Bianchi Italy	14	518 1.5×	646 2.0×	270 1.3×	54 0.3×	37 0.3×	33	873

Countries citing papers authored by Judith van Holten

Since Specialization

Citations

This map shows the geographic impact of Judith van Holten's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Judith van Holten with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Judith van Holten more than expected).

Fields of papers citing papers by Judith van Holten

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Judith van Holten. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Judith van Holten. The network helps show where Judith van Holten may publish in the future.

Co-authorship network of co-authors of Judith van Holten

This figure shows the co-authorship network connecting the top 25 collaborators of Judith van Holten. A scholar is included among the top collaborators of Judith van Holten based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Judith van Holten. Judith van Holten is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

12 of 12 papers shown

Hayashi, Tomoyuki, Yumie Takeshita, Yvan Hutin, et al.. (2021). The global hepatitis delta virus (HDV) epidemic: what gaps to address in order to mount a public health response?. Archives of Public Health. 79(1). 180–180. 20 indexed citations

Tan, Mingjuan, Ajeet Singh Bhadoria, Fuqiang Cui, et al.. (2020). Estimating the proportion of people with chronic hepatitis B virus infection eligible for hepatitis B antiviral treatment worldwide: a systematic review and meta-analysis. The Lancet. Gastroenterology & hepatology. 6(2). 106–119. 105 indexed citations

Funk, Anna, Ying Lu, Kyoko Yoshida, et al.. (2020). Efficacy and safety of antiviral prophylaxis during pregnancy to prevent mother-to-child transmission of hepatitis B virus: a systematic review and meta-analysis. The Lancet Infectious Diseases. 21(1). 70–84. 115 indexed citations

Zoratti, Michael J., Dena Zeraatkar, Roger Chou, et al.. (2020). Pangenotypic direct acting antivirals for the treatment of chronic hepatitis C virus infection: A systematic literature review and meta-analysis. EClinicalMedicine. 18. 100237–100237. 62 indexed citations

Boucheron, Pauline, Ying Lu, Kyoko Yoshida, et al.. (2020). Accuracy of HBeAg to identify pregnant women at risk of transmitting hepatitis B virus to their neonates: a systematic review and meta-analysis. The Lancet Infectious Diseases. 21(1). 85–96. 74 indexed citations

Holten, Judith van. (2006). Interferon beta for the treatment of rheumatoid arthritis. UvA-DARE (University of Amsterdam). 2 indexed citations

Adriaansen, Janik, et al.. (2006). Intraarticular Interferon- β Gene Therapy Ameliorates Adjuvant Arthritis in Rats. Human Gene Therapy. 17(10). 985–996. 27 indexed citations

Holten, Judith van, et al.. (2005). Expression of interferon β in synovial tissue from patients with rheumatoid arthritis: comparison with patients with osteoarthritis and reactive arthritis. Annals of the Rheumatic Diseases. 64(12). 1780–1782. 78 indexed citations

Holten, Judith van, Kris A. Reedquist, Tom Smeets, et al.. (2004). Treatment with recombinant interferon-β reduces inflammation and slows cartilage destruction in the collagen-induced arthritis model of rheumatoid arthritis. Arthritis Research & Therapy. 6(3). R239–49. 127 indexed citations

10.

Holten, Judith van, et al.. (2004). A multicentre, randomised, double blind, placebo controlled phase II study of subcutaneous interferon beta-1a in the treatment of patients with active rheumatoid arthritis. Annals of the Rheumatic Diseases. 64(1). 64–69. 77 indexed citations

11.

Holten, Judith van, et al.. (2004). Local interferon-β gene therapy ameliorates adjuvant arthritis in rats. Arthritis Research. 6(Suppl 1). 54–54. 1 indexed citations

12.

Holten, Judith van, C Plater-Zyberk, & Paul P. Tak. (2002). Interferon-beta for treatment of rheumatoid arthritis?. Arthritis Research. 4(6). 346–346. 46 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact